- Home
- KWR
KWR
Quaker Houghton
as 08-22-2025 4:00pm EST
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
| Founded: | 1918 | Country: | United States |
| Employees: | N/A | City: | CONSHOHOCKEN |
| Market Cap: | 2.2B | IPO Year: | 1985 |
| Target Price: | $148.60 | AVG Volume (30 days): | 159.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.40 | EPS Growth: | N/A |
| 52 Week Low/High: | $95.91 - $180.97 | Next Earning Date: | 07-31-2025 |
| Revenue: | $1,832,674,000 | Revenue Growth: | -3.09% |
| Revenue Growth (this year): | 1.16% | Revenue Growth (next year): | 5.16% |
Latest Quaker Houghton News
KWR Breaking Stock News: Dive into KWR Ticker-Specific Updates for Smart Investing
Argus Research
2 months ago
KWR: Raising target price to $93.00
Insider Monkey
2 months ago
Jefferies Turns Bullish on Quaker Chemical, Sees Upside Potential
Argus Research
2 months ago
KWR: Raising target price to $126.00
TipRanks
2 months ago
Tesla, Intuitive Surgical downgraded: Wall Street’s top analyst calls
Yahoo Finance Video
3 months ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
3 months ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
GlobeNewswire
3 months ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
3 months ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Compare KWR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KWR Quaker Houghton - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.